William Blair Upgrades CRISPR Therapeutics (CRSP) to Outperform
William Blair analyst Raju Prasad upgraded CRISPR Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
